Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Nature Communications|July 12, 2024
Rare de novo damaging DNA variants are enriched in attention-deficit/hyperactivity disorder and implicate risk genesEmily Olfson, Luis C Farhat, Wenzhong Liu, et al.Biological Psychiatry Global Open Science|October 27, 2025
Trichotillomania and Risk of Alcohol- and Drug-Related ProblemsLuis C Farhat, Kayoko Isomura, Ralf Kuja-Halkola, et al.Scientific Reports|March 27, 2025
Sociodemographic and clinical characteristics of 1,234 individuals diagnosed with trichotillomania in the Swedish National Patient RegisterLuis C Farhat, Kayoko Isomura, Lorena Fernández de la Cruz, et al.The Lancet. Psychiatry|October 20, 2025
Psychotic symptoms during pharmacological treatment of ADHD: clinical considerations and research needsSamuele Cortese, Miguel Garcia-Argibay, Dominic Oliver, et al.The Lancet. Psychiatry|December 19, 2024
Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysisEdoardo G Ostinelli, Marcel Schulze, Caroline Zangani, et al.The Lancet. Psychiatry|April 9, 2025
Comparative cardiovascular safety of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysisLuis C Farhat, Alice Lannes, Cinzia Del Giovane, et al.Journal of Child and Adolescent Psychopharmacology|June 19, 2026
Tool for Converting ADHD Rating Scales Scores Based on Individual Participant Data from 53 Randomized Controlled Trials of ADHD MedicationsChristos Christogiannis, Miguel Garcia-Argibay, Anneka Tomlinson, et al.Journal of Child and Adolescent Psychopharmacology|December 4, 2019
Measuring Treatment Response in Pediatric Trichotillomania: A Meta-Analysis of Clinical TrialsLuis C Farhat, Emily Olfson, Jessica L S Levine, et al.European Child & Adolescent Psychiatry|December 3, 2024
Enhanced neurobiological biomarker differentiation for attention-deficit/hyperactivity disorder through a risk-informed designIgor Duarte, Mauricio Scopel Hoffmann, Giovanni A Salum, et al.Molecular Psychiatry|September 8, 2023
Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease studySamuele Cortese, Minjin Song, Luis C Farhat, et al.Pageof 6